Target intelligence / Profile preview

Multiple immune cell types and cytokine networks

Molecular classification
Other
01

Overview

Multiple immune cell types and cytokine networks represent the integrated biological system responsible for host defense and tissue homeostasis. This system comprises diverse cell populations, including T lymphocytes, B lymphocytes, myeloid cells, and natural killer cells, which communicate via a complex array of secreted proteins known as cytokines such as interleukins and interferons [Dinarello, C. A. (2007). Eur J Immunol]. In pathological states such as cancer, the immune network may be co-opted to support tumor growth, while in autoimmune diseases, the network becomes hyperactive against self-tissues [Spangler, J. B., et al. (2015). Annu Rev Immunol]. Therapeutic intervention typically involves targeting specific components of these networks—such as blocking a single cytokine or activating a specific cell surface receptor—to shift the overall balance of the immune response [Waldmann, T. A. (2018). Cold Spring Harb Perspect Biol]. Because of the high degree of redundancy and pleiotropy within these networks, affecting one node often results in systemic shifts across the entire immune landscape, presenting both therapeutic opportunities and significant safety challenges [Commins, S. P., et al. (2010). J Allergy Clin Immunol]. Understanding the spatial and temporal dynamics of these interactions is essential for the development of precision immunotherapies. Modern drug discovery often focuses on multi-specific antibodies or combination therapies to address the complexity of these networks.

Other names
Immune systemCytokine milieuImmune microenvironmentInflammatory networkImmune landscape
02

Mechanism of action

Modulation of immune cell activation, differentiation, and cytokine-mediated signaling pathways to restore homeostasis or enhance anti-tumor activity.

03

Biological functions

Immune responseSignal transductionInflammationCell-cell communicationHost defenseTissue homeostasis
04

Disease associations

CancerAutoimmune diseaseInfectionInflammationGraft-versus-host disease
05

Safety considerations

Cytokine release syndrome (CRS)ImmunosuppressionIncreased risk of opportunistic infectionAutoimmune-related adverse events (irAEs)Infusion reactions
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor Necrosis Factor-alpha (TNF-α)C-reactive protein (CRP)Absolute lymphocyte countCytokine profiles

Beyond the preview

Go deeper on Multiple immune cell types and cytokine networks.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple immune cell types and cytokine networks.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call